Cita APA

Blevins, T. C., Barve, A., Raiter, Y., Aubonnet, P., Athalye, S., Sun, B., & Muniz, R. (2019). Efficacy and safety of MYL‐1501D versus insulin glargine in people with type 1 diabetes mellitus: Results of the INSTRIDE 3 phase 3 switch study. Diabetes Obes Metab.

Chicago Style Citation

Blevins, Thomas C., Abhijit Barve, Yaron Raiter, Patrick Aubonnet, Sandeep Athalye, Bin Sun, i Rafael Muniz. "Efficacy and Safety of MYL‐1501D Versus Insulin Glargine in People With Type 1 Diabetes Mellitus: Results of the INSTRIDE 3 Phase 3 Switch Study." Diabetes Obes Metab 2019.

Cita MLA

Blevins, Thomas C., et al. "Efficacy and Safety of MYL‐1501D Versus Insulin Glargine in People With Type 1 Diabetes Mellitus: Results of the INSTRIDE 3 Phase 3 Switch Study." Diabetes Obes Metab 2019.

Atenció: Aquestes cites poden no estar 100% correctes.